SCHEMBL366514

SCHEMBL366514

CS(=O)(=O)NC(=O)c1ccc(OCc2ccc(F)cc2Cl)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 5/20 0.59
ADAMTS4 O75173 3/20 0.59
MMP13 P45452 3/20 0.59
MMP2 P08253 2/20 0.59
MMP14 P50281 2/20 0.59
SCN9A Q15858 4/20 0.54
SCN5A Q14524 1/20 0.54
MMP1 P03956 8/20 0.53
ADAMTS7 Q9UKP4 3/20 0.52
ADAM17 P78536 3/20 0.51
ADAMTS1 Q9UHI8 2/20 0.51
MAOB P27338 1/20 0.51
TNF P01375 1/20 0.51
MMP3 P08254 1/20 0.51
MMP9 P14780 1/20 0.51
MMP8 P22894 1/20 0.51
NR4A2 P43354 1/20 0.49
EPHX2 P34913 1/20 0.48
NR1H4 Q96RI1 1/20 0.48
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14890261 0.88 NR4A2 (0.64) ADAMTS5ADAMTS4MMP13MMP2MMP14
SCHEMBL14890039 0.88 MAOB (0.67) SCN9ASCN5AMMP1ADAM17MAOB
SCHEMBL14890368 0.86 SCN9A (0.54) SCN9ASCN5AMMP1MAOB
SCHEMBL14890410 0.84 SCN9A (0.57) SCN9ASCN5AMMP1ADAM17MAOB
SCHEMBL364245 0.83 MAOA (0.65) SCN9ASCN5AMMP1ADAM17MAOB
SCHEMBL366136 0.83 SCN9A (0.49) SCN9ASCN5ANR4A2EPHX2NR1H4
SCHEMBL363727 0.82 SCN9A (0.64) SCN9ASCN5ANR4A2
SCHEMBL10397867 0.82 L3MBTL1 (0.58) ADAMTS5ADAMTS4MMP13MMP2MMP14
SCHEMBL365034 0.81 SCN9A (0.54) ADAMTS4MMP13SCN9ASCN5AMMP1
SCHEMBL366812 0.80 MAOB (0.63) ADAMTS4MMP13MMP2MMP14SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096500-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-04 US disclosed
EP-2593428-B1 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS PFIZER LTD (GB) 2014-11-19 EP disclosed
EP-2593428-A2 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS Pfizer Limited (GB) 2013-05-22 EP disclosed
US-20130109701-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 US disclosed
WO-2012007868-A2 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109701-A1 Chemical Compounds SCN1A, SCN1B, SCN7A ADAMTS5 3274/4885ADAMTS4 4151/4885MMP13 4508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.